| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/09/2006 | WO2005112885A3 Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1 |
| 02/09/2006 | WO2005108617A3 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 02/09/2006 | WO2005086896A3 Delivery vectors for short interfering rna, micro-rna and antisense rna |
| 02/09/2006 | WO2005083094A3 Plants having increased yield and method for making the same |
| 02/09/2006 | WO2005077022A3 Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
| 02/09/2006 | WO2005074647A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 02/09/2006 | WO2005070044A3 Systems and methods for short rna expression |
| 02/09/2006 | WO2005063980A8 METHOD OF ENZYMATICALLY CONSTRUCTING RNAi LIBRARY |
| 02/09/2006 | WO2005027825A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/09/2006 | WO2005014794A3 Generation of low phytate plants by molecular disruption of inositol polyphosphate kinases |
| 02/09/2006 | WO2005010038A3 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 02/09/2006 | WO2004113517A3 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 02/09/2006 | WO2004056983A3 Metalloprotease proteins |
| 02/09/2006 | WO2004050839A3 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 02/09/2006 | WO2004028478A3 Functional mutations in respiratory syncytial virus |
| 02/09/2006 | WO2003068923A3 Signal for packaging of influenza virus vectors |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031968 Isolated plant deoxyhypusine synthase and nucleotides encoding same |
| 02/09/2006 | US20060031967 Compositions and methods for modulation of plant cell division |
| 02/09/2006 | US20060031966 Producing genetically engineered plants with increased sensitivity to abscisic acid, drought tolerance, productivity and yields; age resistance; enzyme inhibitors |
| 02/09/2006 | US20060031965 In- seed expression of lysosomal enzymes |
| 02/09/2006 | US20060031964 Plastid genetic engineering via somatic embryogenesis |
| 02/09/2006 | US20060031963 Method for the production of ketocarotinoids in flower petals on plants |
| 02/09/2006 | US20060031962 Antifungal polypeptides |
| 02/09/2006 | US20060031961 Aldehyde reductase |
| 02/09/2006 | US20060031960 Sequence-determined DNA encoding AP2 domain polypeptides |
| 02/09/2006 | US20060031959 Nucleic acid fragments encoding proteins involved in stress response |
| 02/09/2006 | US20060031958 Soybean cultivar 943013 |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060031955 Novel culture systems for EX vivo development |
| 02/09/2006 | US20060031954 FcRn-based therapeutics for the treatment of auto-immune disorders |
| 02/09/2006 | US20060031950 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 02/09/2006 | US20060031949 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031948 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031947 Novel mutated mammalian cells and animals |
| 02/09/2006 | US20060031946 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 02/09/2006 | US20060031945 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060030709 PNA monomer and precursor |
| 02/09/2006 | US20060030538 Methods for reducing or preventing localized fibrosis using SiRNA |
| 02/09/2006 | US20060030535 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics |
| 02/09/2006 | US20060030534 Alzheimer's, Parkinson's, multiple sclerosis, schizophrenia, epilepsy, depression and pain |
| 02/09/2006 | US20060030488 Growing transgenic plants which are able to metabolize synthetic auxin; applying a synthetic auxin to the plants during their growth, and harvesting the crop |
| 02/09/2006 | US20060030487 Materials and methods for the regeneration of plants from cultured plant tissue |
| 02/09/2006 | US20060030048 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030047 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030046 Polypeptide of given sequence; improved efficiency by using heparin binding domain derived from fibronectin; replication deficient vector |
| 02/09/2006 | US20060030045 Antisense modulation of c/ebp beta expression |
| 02/09/2006 | US20060030022 Compositions and methods for production of disulfide bond containing proteins in host cells |
| 02/09/2006 | US20060030020 Lambdoid bacteriophage vectors for expression of foreign proteins |
| 02/09/2006 | US20060030019 HDAC9 polypeptides and polynucleotides and uses thereof |
| 02/09/2006 | US20060030015 Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof |
| 02/09/2006 | US20060030014 Synthesis of polyhydroxyalkanoates in the cytosol of yeast |
| 02/09/2006 | US20060030011 Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| 02/09/2006 | US20060030010 Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in Methylophilus methylotrophus |
| 02/09/2006 | US20060030009 Amino acid producing strains belonging to the genus Escherichia and a method for producing an amino acid |
| 02/09/2006 | US20060030006 Identification of a conserved region of plasmodium falciparum MSP3 targeted by biologically active antibodies |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030004 Solid phase synthesis |
| 02/09/2006 | US20060030003 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |
| 02/09/2006 | US20060030002 Isoforms of the human Vitamin D receptor |
| 02/09/2006 | US20060030001 Useful polypeptides |
| 02/09/2006 | US20060029999 Nucleic acid sequences having an activity of regulating translation efficiency and utilization thereof |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029989 Targeting cells having Mad2 mutation for treatment and/or prevention of disease |
| 02/09/2006 | US20060029984 PSP94 diagnostic reagents and assays |
| 02/09/2006 | US20060029983 Methods of screening compounds for GRK6 modulating activity |
| 02/09/2006 | US20060029972 Method for nucleic acid extraction and nucleic acid purification |
| 02/09/2006 | US20060029968 Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029965 System for fluorescence monitoring |
| 02/09/2006 | US20060029959 Detection method of detecting nucleic acid amplification reaction product and kit for detecting nucleic acid |
| 02/09/2006 | US20060029958 Method for the identification and isolation of strong bacterial promoters |
| 02/09/2006 | US20060029947 Combinatorial protein library screening by periplasmic expression |
| 02/09/2006 | US20060029946 Live cell biosensors |
| 02/09/2006 | US20060029945 Novel full length cDNA |
| 02/09/2006 | US20060029940 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 02/09/2006 | US20060029939 Decomposition and modification of silicate and silicone by silase and use of the reversible enzyme |
| 02/09/2006 | US20060029938 Novel method of highly sensitive nucleic acid analysis |
| 02/09/2006 | US20060029936 UV excitable energy transfer reagents |
| 02/09/2006 | US20060029935 Compositions and methods for rapidly generating recombinant nucleic acid molecules |
| 02/09/2006 | US20060029934 Reverse transcribing and amplifying HIV RNA with primer specific for IN gene of genome to obtain an amplicon; generating a plasmid comprising a wild-type HIV sequence with a deletion; homologous recombination or ligation; diagnostics, drug screening, pharmacogenetics and drug development |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029619 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 02/09/2006 | US20060029616 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance |
| 02/09/2006 | US20060029615 Novel recombinant T4 phage particle and uses thereof |
| 02/09/2006 | US20060029611 Prevention and treatment of amyloidogenic disease |
| 02/09/2006 | US20060029610 GRP94-based compositions and methods of use thereof |
| 02/09/2006 | US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 02/09/2006 | US20060029598 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 02/09/2006 | US20060029596 Administering to the tumor an adenovirus vector, overexpresses an adenovirus death protein; promoting the death of neoplastic cells; telomerase resistance; anticancer biodrugs |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | US20060029583 Method for the genetic activation of cells and uses of said cells |
| 02/09/2006 | US20060029582 Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy |
| 02/09/2006 | US20060029547 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 02/09/2006 | DE19736343B4 Verfahren zur Erhöhung der Genexpression von Saccharose Synthase Method for increasing the gene expression of saccharose synthase |
| 02/09/2006 | DE102004060340A1 Verfahren zur Erhöhung des Gehalts an mehrfach ungesättigten langkettigen Fettsäuren in transgenen Organismen A process for increasing the content of polyunsaturated long chain fatty acids in transgenic organisms |
| 02/09/2006 | DE102004035543A1 Nucleic acid to be coded for signal peptide-peptidase A, to give genes/genetic products for protein production through microorganisms, has a defined nucleotide sequence |
| 02/09/2006 | DE102004035076A1 P2-10-Expressionseinheiten P2-10 expression units |
| 02/09/2006 | DE102004034461A1 Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren Gene therapy of solid tumors by retroviral, with arena virus glycoprotein pseudotyped vectors |